Pythiosis in Dogs: Symptoms, Diagnosis, Treatment, and Gulf Coast Guide
This article is reviewed for clinical accuracy. Always consult your veterinarian for diagnosis and treatment.
Key Takeaways
- Pythiosis is caused by Pythium insidiosum, an oomycete (water mold) that is classified in the kingdom Stramenopila rather than in the kingdom Fungi; this taxonomic distinction is not merely academic: Pythium insidiosum lacks ergosterol in its cell membrane (unlike true fungi, which rely on ergosterol as a structural component), and because the mechanism of action of nearly all conventional antifungal agents (azoles, amphotericin B, echinocandins) depends on targeting ergosterol or ergosterol biosynthesis, standard antifungal drugs have minimal to no activity against Pythium insidiosum; a dog diagnosed with pythiosis cannot be treated with the same antifungal drugs used for blastomycosis, histoplasmosis, valley fever, cryptococcosis, or aspergillosis, and empirical treatment with these agents while awaiting a specific diagnosis will not slow disease progression.
- Dogs acquire pythiosis by direct contact with aquatic environments (ponds, swamps, ditches, rice paddies, slow-moving streams, and flooded pastures) where Pythium insidiosum produces motile biflagellate zoospores; the zoospores are chemotactically attracted to damaged or disrupted mucosal and cutaneous surfaces (wounds, inflamed skin, abraded gastrointestinal mucosa) where they encyst and germinate into hyphae that invade the host tissue; because exposure requires contact with infected standing or slow-moving water in tropical and subtropical environments, pythiosis in dogs is strongly geographically restricted to the Gulf Coast states of the United States (Texas, Louisiana, Mississippi, Alabama, Florida) and is most common in fall and late summer when water levels are highest and zoospore concentrations in the environment peak; dogs that swim regularly in ponds, bayous, or drainage ditches in these states carry the highest risk; Labrador Retrievers, Golden Retrievers, and other water-loving sporting breeds are consistently overrepresented in canine pythiosis case series, reflecting both their geographic prevalence in the Gulf Coast and their affinity for aquatic environments.
- Gastrointestinal pythiosis is the most common form in dogs and produces a distinctive mass lesion (the pythioma) within the wall of the stomach, small intestine, or colorectum; the pythioma is a firm, circumferential or segmental thickening of the bowel wall caused by granulomatous and eosinophilic inflammation driven by a robust but futile host immune response against the hyphae; on abdominal ultrasound the pythioma appears as a markedly thickened, irregular, hypoechoic to mixed-echogenicity mass involving a segment of stomach or intestine with regional mesenteric lymphadenopathy; the ultrasound appearance closely mimics alimentary lymphoma and intestinal adenocarcinoma, and biopsy with histopathology is essential to distinguish pythiosis from GI neoplasia; key histological findings include severe eosinophilic granulomatous inflammation, eosinophilic “flame figures” (deposits of eosinophil granule contents surrounding hyphae), broad (4 to 9 micrometers diameter) sparsely septate or aseptate hyphae that stain with Gomori methenamine silver (GMS) or periodic acid-Schiff (PAS) but do not stain with standard hematoxylin and eosin, and the absence of vascular invasion (distinguishing pythiosis from mucormycosis/zygomycosis).
- The Pythium insidiosum ELISA serology test developed at Louisiana State University School of Veterinary Medicine (the LSU ELISA) is the most sensitive and specific diagnostic test for canine pythiosis and should be among the first diagnostic steps for any dog in the Gulf Coast region with a GI mass or non-healing skin lesion; the LSU ELISA detects IgG antibodies against Pythium insidiosum antigens and has sensitivity above 90 percent and specificity above 95 percent for confirmed pythiosis cases; because the zoospores trigger a vigorous immune response, antibody titers develop early in infection and are present in most dogs with active disease; the ELISA titer can also be used to monitor treatment response: a declining titer correlates with disease control; false negatives are uncommon in clinical disease but can occur in dogs with severe immunosuppression; the ELISA is performed at the LSU SVM Diagnostic Laboratory and at a small number of reference laboratories that offer the test.
- Surgical resection with wide margins is the only treatment approach with proven potential for cure in gastrointestinal pythiosis; because the pythioma extends microscopically beyond its gross boundaries, narrow surgical margins consistently result in incomplete resection and local recurrence; a minimum of 2 to 4 centimeters of grossly normal tissue beyond the visible edge of the mass is the standard recommendation for resection margins; the prognosis after surgical resection depends primarily on whether histopathological margins are clear: dogs with histologically confirmed clear margins have reported survival times of 1 to 2 years and occasional long-term survivors, while dogs with incomplete resection almost universally relapse within weeks to months; adjunctive medical therapy with itraconazole plus terbinafine (the Grooters protocol from LSU) is used after surgery and in dogs with unresectable disease, though the mechanisms of action in Pythium (which lacks ergosterol) are not fully understood and medical therapy alone rarely achieves cure; amphotericin B and the standard azoles (fluconazole, itraconazole, voriconazole) used alone have no reliable efficacy against Pythium insidiosum.
- Cutaneous pythiosis produces non-healing ulcerated skin lesions with draining tracts, typically on the limbs, tail base, perineum, or ventral trunk; the lesions expand progressively, developing a firm, fibrous surrounding reaction with central ulceration and multiple punctate sinus tracts; unlike cutaneous lesions from bacterial infection or dermatophytosis, cutaneous pythiomas do not respond to antibiotics or antifungal drugs and continue to enlarge despite treatment; amputation of the affected limb may be curative for cutaneous pythiosis limited to a distal limb when there is no evidence of regional lymph node or systemic involvement; the LSU ELISA should be performed on any Gulf Coast dog with a non-healing, expanding, draining skin lesion that has not responded to antibiotics, antifungals, and standard wound management.
The 3-year-old Labrador Retriever presented for a 6-week history of weight loss, intermittent vomiting, and progressive lethargy. She lived in coastal Louisiana and swam regularly in the bayou behind her owner’s property. On physical examination she was thin (body condition score 2 out of 9), and abdominal palpation revealed a firm, non-painful mid-abdominal mass. Abdominal ultrasound showed a 7-centimeter segmental thickening of the proximal jejunum with markedly irregular, hypoechoic walls and regional mesenteric lymphadenopathy. The referring veterinarian had considered lymphoma as the primary diagnosis and submitted a fine-needle aspirate of the mass for cytology, which showed eosinophilic granulomatous inflammation but no lymphoma cells. Before proceeding to surgery or chemotherapy, the internal medicine consultant asked about water exposure history and sent an LSU ELISA serology panel for Pythium insidiosum; the result returned the next morning as strongly positive at an optical density ratio of 8.4. She was referred for surgical resection; intraoperatively the mass involved a 12-centimeter segment of jejunum with visible mesenteric extension. Resection was performed with 4-centimeter margins. Histopathology confirmed eosinophilic granulomatous enteritis with GMS-positive broadly aseptate hyphae and clear surgical margins. The dog was started on itraconazole plus terbinafine as adjunctive therapy. Sixteen months postoperatively she was alive with a declining ELISA titer.
The Organism: Oomycete Masquerading as a Fungus
| Feature | Pythium insidiosum | True Fungi (Aspergillus, Blastomyces, etc.) |
|---|---|---|
| Kingdom classification | Stramenopila (also called Chromista or Heterokonta); closely related to brown algae and diatoms; NOT a member of the kingdom Fungi | Kingdom Fungi |
| Cell membrane composition | Lacks ergosterol; cell membrane is composed of cholesterol and other sterols fundamentally different from fungal ergosterol; this is the key reason conventional antifungal drugs are inactive | Ergosterol is the primary sterol; the target of amphotericin B, azoles, and allylamines |
| Infective particle | Motile biflagellate zoospores produced in aquatic environments; chemotactically attracted to disrupted epithelial surfaces; encyst on contact and germinate into hyphae; there are no airborne infective particles (unlike fungi) | Airborne conidia (dimorphic fungi, Aspergillus) or desiccated yeast cells (Cryptococcus); all airborne |
| Hyphal morphology | Broad (4 to 9 micrometers diameter), sparsely septate or aseptate (coenocytic) hyphae; right-angle branching pattern; GMS-positive; no vascular invasion | Varies: Aspergillus has narrow (2 to 4 micrometers) septate hyphae with 45-degree branching; Zygomycetes have broad aseptate hyphae with vascular invasion |
| Host response | Severe eosinophilic granulomatous inflammation; eosinophilic flame figures around hyphae; minimal intracellular invasion (hyphae are too large for phagocytosis); the robust but ineffective host response contributes to the mass lesion character of the pythioma | Varies by species and host immune status; generally pyogranulomatous; macrophage engulfment is important for intracellular fungi |
| Standard antifungal susceptibility | Intrinsically resistant to amphotericin B, azoles (fluconazole, itraconazole, voriconazole), echinocandins (caspofungin, micafungin); itraconazole plus terbinafine combination has partial activity through non-ergosterol mechanisms; no single reliable curative drug exists | Most true fungi respond to amphotericin B, itraconazole, fluconazole, or voriconazole depending on species; MIC testing guides agent selection |
| Geographic distribution | Tropical and subtropical regions with standing warm water; Gulf Coast US (Texas, Louisiana, Mississippi, Alabama, Florida); also reported in Australia, Brazil, Southeast Asia, Caribbean, and Hawaii | Varies; dimorphic fungi have specific endemic zones; Aspergillus and Cryptococcus are worldwide |
Clinical Presentations
Gastrointestinal Pythiosis
GI pythiosis is the most common form in dogs and carries the worst prognosis of all the pythiosis presentations; the pythioma most commonly involves the stomach (antrum and pylorus), the jejunum, the ileum, or the colorectum; gastric pythiosis produces pyloric outflow obstruction with chronic vomiting (often of undigested food), progressive weight loss, and a palpable cranial abdominal mass; intestinal pythiosis produces weight loss, protein-losing enteropathy with hypoalbuminemia and dependent edema, chronic diarrhea, intermittent vomiting, and abdominal mass; colorectal pythiosis produces tenesmus, dyschezia, rectal discharge, and a perirectal or colorectal mass; the onset of clinical signs is typically insidious, with gradual weight loss and intermittent vomiting over weeks to months before the mass becomes palpable or the dog is too ill to eat; by the time most GI pythiosis cases are definitively diagnosed, the mass is already large and the dog is clinically debilitated, which is why early serological screening in dogs from the Gulf Coast with any of these GI signs is important.
Cutaneous and Subcutaneous Pythiosis
Cutaneous pythiosis most commonly affects the distal limbs (especially the paws, pasterns, and distal forelimbs or hindlimbs), the tail base, the perineum, and the ventral trunk; lesions begin as focal areas of swelling, erythema, and ulceration at the site of zoospore entry (typically a wound or abrasion that had contact with contaminated water); as the infection progresses, the lesion develops a firm, fibrous periphery with central ulceration and multiple small draining sinus tracts that discharge a pale yellow to pink watery exudate; pruritus is often intense, and the dog may mutilate the lesion by licking and chewing; the surrounding tissue becomes progressively indurated, and the lesion expands outward in all directions regardless of antibiotic or standard antifungal treatment; regional lymph nodes may enlarge as the infection spreads via lymphatics; a characteristic feature of cutaneous pythiosis is the complete failure of standard wound care, antibiotics, and antifungals to provide any lasting improvement, with the lesion continuing to enlarge despite weeks of treatment.
Diagnosis
LSU Pythium ELISA Serology
The Pythium insidiosum ELISA serology test developed at Louisiana State University School of Veterinary Medicine is the most sensitive and practical diagnostic test for both GI and cutaneous pythiosis in dogs; the test detects serum IgG antibodies directed against Pythium insidiosum antigens and returns results as an optical density ratio with sensitivity above 90 percent and specificity above 95 percent for confirmed pythiosis; the test is performed at the LSU SVM Diagnostic Laboratory (Baton Rouge, Louisiana) and can be ordered by any veterinarian in the US; a strongly positive ELISA result in a dog from the Gulf Coast with a GI mass or non-healing skin lesion essentially confirms the diagnosis and should guide treatment planning without further delay; serial ELISA titers measured at 2 to 3-month intervals monitor treatment response: a sustained decline in titer correlates with disease control after surgical resection or during medical management; a stable or rising titer during treatment indicates inadequate disease control; false negative results occur in early infection before antibody titers have risen to detectable levels and in severely immunosuppressed dogs.
Abdominal Ultrasound (GI Pythiosis)
Abdominal ultrasound is the first-line imaging study for GI pythiosis and demonstrates segmental bowel wall thickening with loss of normal wall layering; the affected segment has irregular, hypoechoic to mixed-echogenicity walls that are markedly thickened (often 1 to 3 centimeters, compared to the normal 2 to 5 millimeters); peristalsis is typically absent in the affected segment; regional mesenteric lymph nodes are often enlarged and have altered echogenicity; the overall ultrasound appearance closely resembles alimentary lymphoma (particularly T-cell lymphoma which also produces transmural wall thickening) and intestinal adenocarcinoma, and differentiation requires either LSU ELISA serology or histopathological examination of a full-thickness biopsy specimen; fine-needle aspirate cytology of the mass typically shows eosinophilic granulomatous inflammation without visible hyphae (hyphae are too large for FNA sampling) and does not distinguish pythiosis from other granulomatous GI diseases.
Histopathology
Full-thickness biopsy (endoscopic biopsies are often too superficial to sample the full transmural extent of the pythioma and may miss diagnostic hyphae) with histopathological examination provides definitive confirmation; sections stained with hematoxylin and eosin show severe eosinophilic granulomatous inflammation with the characteristic eosinophilic flame figures, but hyphae are poorly visible on H&E; Gomori methenamine silver (GMS) or periodic acid-Schiff (PAS) staining is required to visualize the hyphae; the hyphae appear broad (4 to 9 micrometers), have sparse cross-walls (sparsely septate to aseptate), branch at wide angles (approaching 90 degrees but not as regular as Zygomycetes), and are oriented randomly within the inflammatory infiltrate; immunohistochemistry using Pythium-specific antibodies developed at LSU is the most specific confirmatory test on histopathological sections and can be applied to formalin-fixed paraffin-embedded tissue from any laboratory.
Culture
Pythium insidiosum can be cultured from tissue, but requires specific culture conditions: incubation at 37 degrees Celsius and below (not at 42 degrees, unlike Aspergillus), specialized oomycete-specific culture media (cornmeal agar, V8 juice agar, or Pythium-specific media), and an aquatic germination step to induce zoospore release; standard fungal culture media and conditions used in clinical diagnostic laboratories are not optimized for Pythium and produce frequent false-negative results; requesting “Pythium culture” specifically, rather than “fungal culture,” is important when submitting tissue from suspected pythiosis cases; PCR performed on fresh tissue is faster and more sensitive than culture for Pythium identification.
Treatment
Surgical Resection
Wide surgical resection with histologically confirmed clear margins is the only treatment approach with documented potential for cure in GI pythiosis; the surgeon must plan for margins of at least 2 to 4 centimeters of grossly normal tissue on each side of the visible mass edge because Pythium hyphae extend microscopically beyond the grossly visible pythioma boundary; when the pythioma involves the pylorus or gastroduodenal junction, a Billroth I or II gastrojejunostomy may be required; jejunal and ileal pythiomas in favorable locations with adequate remaining bowel length can be resected with end-to-end anastomosis; colorectal pythiomas may require subtotal colectomy; intraoperative assessment of margin adequacy is challenging because the indurated fibrous boundary of the pythioma makes it difficult to assess by palpation where the infection ends; frozen section histopathology during surgery to assess margins in real time is ideal but not universally available; submission of the full resection specimen with ink-marked margins for permanent section histopathology is standard; dogs with clear histopathological margins have the best prognosis, though cure is still not guaranteed because microscopic residual disease beyond the sampled margins may persist.
Adjunctive Medical Therapy: Itraconazole Plus Terbinafine
Because Pythium insidiosum lacks ergosterol, none of the standard antifungal agents work through their typical mechanisms; however, the combination of itraconazole plus terbinafine (the Grooters protocol, named after the veterinary internist at LSU who developed it) has shown partial efficacy in canine pythiosis through mechanisms that likely involve non-ergosterol targets; the protocol is:
- Itraconazole: 10 mg/kg orally once daily with a fatty meal; this is a higher dose than used for most fungal infections (5 mg/kg for blastomycosis/histoplasmosis), reflecting the higher MIC of itraconazole against Pythium compared to true fungi; itraconazole capsules require acidic gastric pH for absorption (give with food that stimulates acid secretion; avoid antacids and proton pump inhibitors during itraconazole therapy); therapeutic drug monitoring of itraconazole serum trough concentrations (target 1 to 5 micrograms/mL) is recommended given the higher dose; liver enzymes should be monitored monthly
- Terbinafine: 5 to 10 mg/kg orally once daily; terbinafine is an allylamine antifungal that normally inhibits squalene epoxidase in the fungal ergosterol biosynthesis pathway; its activity against Pythium is thought to occur through alternative targets; terbinafine is generally well tolerated in dogs; hepatotoxicity is uncommon but liver enzymes should be monitored with long-term use
- Duration: Lifelong or until the LSU ELISA titer declines to negative and remains negative for 3 to 6 months; most dogs with GI pythiosis that survive surgery require 12 to 24 months of medical therapy before the ELISA reaches negative
Medical therapy with itraconazole plus terbinafine alone (without surgical resection) rarely if ever cures GI pythiosis but may slow progression and is used for palliation in dogs with unresectable disease; for cutaneous pythiosis, medical therapy combined with surgical debridement (or amputation of a distal limb) achieves better outcomes than medical therapy alone.
Biological Therapy (Immunotherapy)
A Pythium-specific immunotherapy product containing Pythium insidiosum antigens in adjuvant (developed at LSU) has been used in horses with pythiosis and in a small number of canine cases; the immunotherapy aims to enhance the host immune response against Pythium antigens to supplement the imperfect cellular immune response that the host mounts during natural infection; results in horses have been promising, with some cures reported in early cutaneous pythiosis; data in dogs are limited; immunotherapy is not a commercially available product and requires contact with the LSU research group for access; it is typically used as adjunct to surgery and medical therapy rather than as sole treatment.
US Cost Overview for Pythiosis
| Service | Typical US Cost |
|---|---|
| Veterinary examination | $60 to $150 |
| LSU Pythium ELISA serology | $80 to $150 |
| Complete blood count, chemistry, albumin | $150 to $300 |
| Abdominal ultrasound | $300 to $700 |
| Abdominal CT (surgical planning) | $800 to $2,000 |
| Exploratory laparotomy and intestinal resection | $2,500 to $6,000 |
| Histopathology with GMS staining | $150 to $350 |
| Itraconazole (monthly, 30 kg dog at 10 mg/kg) | $80 to $200 per month |
| Terbinafine (monthly, 30 kg dog) | $30 to $80 per month |
| Itraconazole trough monitoring | $80 to $180 per measurement |
| Monthly liver enzyme monitoring | $80 to $150 |
| Serial LSU ELISA titers (every 2 to 3 months) | $80 to $150 per titer |
| Amputation (cutaneous pythiosis, distal limb) | $1,500 to $4,000 |
Age-Specific Considerations
Puppies (Under 12 Months)
- Pythiosis in puppies is uncommon but is reported; young dogs that begin swimming in Gulf Coast waterways from an early age face environmental exposure from the first months of life; because puppies have a less mature mucosal immune barrier in the GI tract, zoospores that are ingested or contact the intestinal mucosa through swimming water may have greater opportunity for tissue penetration than in adult dogs with a fully mature mucosal immune response; any puppy from the Gulf Coast region with progressive weight loss, vomiting, and a palpable abdominal mass should have a Pythium ELISA performed, particularly if the owner describes regular water access
- Surgical resection of a GI pythioma carries additional risk in puppies because of their smaller bowel diameter, reduced nutritional reserves at presentation (pythiosis-related malnutrition is often severe at diagnosis), and the challenges of performing a wide-margin resection in a small patient; nutritional support (esophagostomy tube feeding or parenteral nutrition) to stabilize the puppy’s body weight before surgery improves anesthetic and surgical outcomes; a puppy that is severely hypoalbuminemic (serum albumin below 1.5 g/dL) is at high risk for surgical dehiscence because albumin is essential for tissue healing and wound strength
- Itraconazole dosing in puppies should be based on body weight at 10 mg/kg once daily, administered with food; puppies have higher hepatic microsomal enzyme activity than adults and may metabolize itraconazole faster, potentially requiring a higher dose per kilogram to achieve target trough concentrations; itraconazole trough monitoring (targeting 1 to 5 micrograms/mL) is recommended in puppies receiving the drug, as in adult dogs; terbinafine is generally well tolerated in puppies at 5 to 10 mg/kg once daily
Adult Dogs (1 to 8 Years)
- Adult dogs between 1 and 5 years are the most commonly affected age group in canine pythiosis case series; the median age at diagnosis is approximately 2 to 4 years in most published reports; young adult sporting and working dogs (Labrador Retrievers, Golden Retrievers, and mixed breeds with water access on Gulf Coast properties) that swim regularly face the highest exposure risk during the summer and fall months when zoospore concentrations in standing water are highest; veterinarians practicing in Texas, Louisiana, Mississippi, Alabama, and Florida should include Pythium ELISA serology in the initial workup of any adult dog with a GI mass and a history of water exposure, rather than pursuing endoscopy and empirical lymphoma treatment before serological testing
- The differential diagnosis of a GI mass in an adult dog from the Gulf Coast includes alimentary lymphoma (the most common GI tumor in dogs), intestinal adenocarcinoma, leiomyosarcoma, and pythiosis; these entities are distinguished by histopathology of a full-thickness biopsy, but the Pythium ELISA provides a faster and less invasive first answer; a negative ELISA in a dog with compatible clinical signs does not exclude pythiosis (false negative rate approximately 5 to 10 percent in confirmed disease), but a strongly positive ELISA in the right clinical context is near-diagnostic and prevents unnecessary empirical chemotherapy for presumed lymphoma in a dog that actually has pythiosis (chemotherapy with corticosteroids in a dog with pythiosis would be strongly immunosuppressive and likely accelerate disease progression)
- For cutaneous pythiosis in adult dogs, limb amputation should be discussed early when the lesion is limited to a distal limb without regional lymph node involvement; the decision is psychologically difficult for owners but offers the best chance of cure for cutaneous disease and dramatically better outcomes than prolonged attempts at medical management of an expanding, non-healing lesion; delaying amputation while trying multiple antibiotic and antifungal regimens allows the lesion to extend proximally toward the trunk, eventually making amputation technically impossible and leaving palliative care as the only option
Senior Dogs (9 Years and Older)
- Senior dogs with GI pythiosis face the same treatment challenge as younger dogs but with added complexity from age-related organ dysfunction; hypoalbuminemia from protein-losing enteropathy (a near-universal finding in GI pythiosis) is more difficult to correct in senior dogs with reduced hepatic synthetic reserve; preoperative albumin supplementation with fresh frozen plasma or 25 percent albumin solution may be required to achieve an acceptable serum albumin above 2.0 g/dL before intestinal resection surgery; surgery on a severely hypoalbuminemic senior dog carries high risk of anastomotic dehiscence and peritonitis, which are fatal complications; deferring surgery until the dog’s nutritional and albumin status is stabilized through enteral or parenteral nutritional support improves surgical outcomes even if it delays the operation by several days
- Itraconazole hepatotoxicity, while uncommon, is more likely in senior dogs with pre-existing hepatic changes common at this age; baseline liver enzymes should be measured before starting itraconazole, and monthly monitoring during the first 3 months of treatment is recommended; dogs with elevated ALT above 3 times the upper reference limit before starting itraconazole should have a hepatic evaluation (abdominal ultrasound, bile acids) before antifungal therapy is initiated; terbinafine is generally better tolerated than itraconazole in dogs with borderline hepatic function
- The decision about surgical resection in a senior dog with GI pythiosis requires honest prognosis counseling; even with a successful surgery and confirmed clear margins, pythiosis carries a substantial relapse rate (approximately 30 to 50 percent in published series) and requires years of expensive medical monitoring; a senior dog with concurrent chronic kidney disease, cardiac disease, or other life-limiting conditions may have a better quality of life with palliative medical management (itraconazole plus terbinafine to slow progression) rather than aggressive surgery; the owner’s values, the dog’s quality of life, and a realistic assessment of expected survival should guide the conversation
Myths and Facts About Pythiosis in Dogs
Pythiosis is a type of fungal infection, so standard antifungal medications should work.
Pythium insidiosum is not a fungus. It is an oomycete belonging to a completely different kingdom (Stramenopila) and lacks ergosterol, the cell membrane component that is the target of amphotericin B, azoles, and echinocandins. Treating pythiosis with fluconazole, itraconazole alone, voriconazole, or amphotericin B as monotherapy has no reliable efficacy. The only proven effective drug combination (itraconazole plus terbinafine) works through mechanisms unrelated to ergosterol inhibition, and surgical resection remains the cornerstone of treatment.
My dog’s abdominal mass is lymphoma because the biopsy showed eosinophilic inflammation, not cancer cells.
Eosinophilic granulomatous inflammation on a GI biopsy in a dog from the Gulf Coast region is the characteristic histological pattern of pythiosis, not of lymphoma. Lymphoma produces a monomorphic population of neoplastic lymphocytes; pythiosis produces severe eosinophilic and granulomatous inflammation with no neoplastic cells. Any Gulf Coast dog with a GI mass and eosinophilic granulomatous inflammation on biopsy should have a Pythium ELISA serology test performed immediately before chemotherapy or other treatment is started.
My dog only went near water once, so he couldn’t have pythiosis.
A single exposure to contaminated water is sufficient for zoospore contact with disrupted mucosal or cutaneous surfaces to initiate infection. The motile zoospores are chemotactically attracted to wounded or inflamed tissue and can encyst and germinate into hyphae within minutes of contact. Dogs with a gastric or intestinal mucosal injury from any cause (dietary indiscretion, foreign body trauma, parasitism) that then have even brief contact with contaminated water can develop GI pythiosis from a single exposure event.
Red Flags: Signs Requiring Prompt Veterinary Evaluation
- Progressive weight loss, chronic vomiting, and a palpable abdominal mass in any dog from Texas, Louisiana, Mississippi, Alabama, or Florida with a history of swimming in ponds, bayous, ditches, or any standing water: this combination represents GI pythiosis until proven otherwise; the window for potentially curative surgical resection closes as the mass grows and as the dog’s nutritional status deteriorates; prompt referral to an internal medicine specialist or surgical oncologist with familiarity with pythiosis, combined with immediate LSU ELISA serology testing, is the appropriate response to this presentation
- An expanding, non-healing skin lesion with draining tracts on the limbs, tail base, or perineum of a Gulf Coast dog that has not responded to multiple antibiotic and antifungal treatment courses: this pattern is the clinical definition of cutaneous pythiosis; each week of continued medical treatment without a definitive diagnosis and surgical planning allows the pythioma to extend proximally, potentially converting an amputable distal limb lesion into an unresectable trunk lesion; LSU ELISA serology and referral for biopsy should be pursued as soon as non-response to standard wound care becomes apparent
- Severe hypoalbuminemia (serum albumin below 1.5 g/dL) in a young adult dog from the Gulf Coast with GI disease: hypoalbuminemia this severe in a young dog without known hepatic disease or renal protein loss is a red flag for protein-losing enteropathy from pythiosis, inflammatory bowel disease, or intestinal lymphoma; ascites, peripheral edema, and pleural effusion secondary to oncotic pressure loss may develop; nutritional stabilization and specific diagnostic workup including Pythium ELISA and full-thickness GI biopsy are urgent
- A Gulf Coast dog receiving corticosteroids for presumed eosinophilic gastroenteritis or inflammatory bowel disease that is deteriorating rather than improving: corticosteroid treatment of pythiosis is actively harmful because corticosteroids suppress the macrophage and neutrophil response against Pythium hyphae, potentially accelerating hyphal invasion and mass expansion; any Gulf Coast dog with eosinophilic GI disease that worsens on corticosteroids should be tested for pythiosis before the steroid dose is escalated
- Tenesmus, rectal discharge, and a perirectal or colorectal mass in a Gulf Coast dog: colorectal pythiosis is less common than gastric or small intestinal forms but causes significant morbidity through bowel obstruction, perirectal pain, and fistula formation; it is frequently misdiagnosed as perianal fistula or rectal adenocarcinoma; LSU ELISA serology combined with full-thickness rectal biopsy and GMS staining is required to confirm the diagnosis before surgical planning
Frequently Asked Questions About Pythiosis in Dogs
What is pythiosis in dogs?
Pythiosis is caused by Pythium insidiosum, an oomycete (water mold) classified in the kingdom Stramenopila rather than the kingdom Fungi. It is not a true fungal infection. Dogs acquire it by contact with contaminated standing water in Gulf Coast states where motile zoospores enter through damaged skin or intestinal mucosa. The GI form produces a firm bowel wall mass (pythioma) mimicking cancer; the cutaneous form produces non-healing draining skin lesions. Standard antifungal drugs are ineffective because Pythium lacks ergosterol.
What are the symptoms of pythiosis in dogs?
GI pythiosis causes progressive weight loss, chronic vomiting, protein-losing enteropathy, and a palpable abdominal mass, typically in young adult dogs from Texas, Louisiana, Mississippi, Alabama, or Florida. Cutaneous pythiosis produces expanding, non-healing ulcerated lesions with draining tracts on the limbs, tail base, or perineum. Both forms fail to respond to antibiotics and standard antifungal drugs. A history of swimming in ponds, bayous, or drainage ditches is an important risk factor.
How is pythiosis diagnosed in dogs?
The LSU Pythium insidiosum ELISA serology test (performed at Louisiana State University School of Veterinary Medicine) is the most sensitive and specific diagnostic test, with sensitivity above 90 percent and specificity above 95 percent. Abdominal ultrasound demonstrates the GI mass. Definitive confirmation requires full-thickness biopsy with histopathology using Gomori methenamine silver staining to visualize the broad, sparsely septate hyphae within the eosinophilic granulomatous inflammation. Immunohistochemistry with Pythium-specific antibodies is the gold standard on tissue sections.
Can pythiosis in dogs be cured?
Cure is possible but requires early diagnosis and wide-margin surgical resection with histologically confirmed clear margins. Dogs with GI pythiosis who undergo complete resection and receive adjunctive itraconazole plus terbinafine have survival times of 1 to 2 years or longer in the best outcomes, with occasional long-term survivors. However, relapse occurs in approximately 30 to 50 percent of surgically treated dogs, and medical therapy alone rarely cures GI pythiosis. Cutaneous pythiosis of a distal limb can be cured by amputation if there is no regional spread.
Why don’t regular antifungal drugs work for pythiosis?
Pythium insidiosum lacks ergosterol in its cell membrane, which is the molecular target of amphotericin B, azoles (fluconazole, itraconazole, voriconazole), and allylamines when used at standard doses. Without ergosterol, these drugs have no relevant binding target in Pythium and therefore no reliable antifungal activity. The itraconazole plus terbinafine combination used for pythiosis is thought to work through alternative cellular targets rather than ergosterol, and its efficacy is partial rather than curative.
Where is pythiosis most common in dogs?
Pythiosis in dogs in the United States is restricted almost entirely to the Gulf Coast states: Texas, Louisiana, Mississippi, Alabama, and Florida, with the highest case density in coastal Louisiana and East Texas. The disease requires standing warm water (above 20 degrees Celsius) for zoospore production and is most prevalent in late summer and fall. Dogs that swim in bayous, drainage ditches, rice paddies, flooded pastures, or any slow-moving warm water in these states face the highest risk. Labrador and Golden Retrievers are the most commonly affected breeds due to their affinity for water.
Can my dog get pythiosis from another dog?
No. Pythiosis is not transmitted directly between dogs or between dogs and humans. Each case acquires the infection independently from the same environmental source: aquatic environments containing Pythium insidiosum zoospores. The zoospores require specific warm aquatic conditions to survive and are not present in the air, dry soil, or on other animals. Standard hygiene when handling a dog with draining cutaneous pythiosis lesions is sufficient precaution; there is no documented risk of dog-to-human transmission.
For more guides on keeping your dog healthy, browse all our Dog Health articles.
Explore Dog Health Articles